NR4A1 and neoplasm: Patients with MBC were more likely to be older age (≥ 65 years) (p < 0.001), non-Hispanic Black (p < 0.001), have poorly/undifferentiated disease (p < 0.001), larger tumor size (p < 0.001), nodal-negative (p < 0.001), and hormone receptor negative disease (p < 0.001).